Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults

(2017) Scott A. Halperin et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

(2017) Ana Maria Henao-Restrepo et al.   LANCET

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

(2017) Jason A. Regules et al.   NEW ENGLAND JOURNAL OF MEDICINE

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa

(2017) Angela Huttner et al.   Science Translational Medicine

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

(2017) Christine Dahlke et al.   EBioMedicine

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

(2016) Milagritos D Tapia et al.   LANCET INFECTIOUS DISEASES

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

(2016) Selidji T. Agnandji et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ebola vaccines in clinical trial: The promising candidates

(2016) Yuxiao Wang et al.   Human Vaccines & Immunotherapeutics

Global health security: the wider lessons from the west African Ebola virus disease epidemic

(2015) David L Heymann et al.   LANCET

Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola

(2015) Suerie Moon et al.   LANCET

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

(2015) Ana Maria Henao-Restrepo et al.   LANCET

Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort

(2015) Julie E Ledgerwood   LANCET INFECTIOUS DISEASES

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

(2015) Angela Huttner et al.   LANCET INFECTIOUS DISEASES

Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus

(2015) Verena Krähling et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Ebola vaccine R&D: Filling the knowledge gaps

(2015) Donata Medaglini et al.   Science Translational Medicine

Ebola Vaccine — An Urgent International Priority

(2014) Rupa Kanapathipillai et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mapping the zoonotic niche of Ebola virus disease in Africa

(2014) David M Pigott et al.   eLife

Reston ebolavirus in Humans and Animals in the Philippines: A Review

(2011) Mary Elizabeth G. Miranda et al.   JOURNAL OF INFECTIOUS DISEASES

High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon

(2010) Pierre Becquart et al.   PLoS One